FINWIRES · TerminalLIVE
FINWIRES

Norwegian Cruise Line Likely to See Prolonged Turnaround, Morgan Stanley Says

By

Norwegian Cruise Line (NCLH) could see a prolonged turnaround after the company cut its 2026 guidance on declining yields and higher fuel costs, Morgan Stanley said in a note Tuesday.

"The sudden change in yield guidance implies a material deterioration in a short window given ~80%+ of a quarter out

is already booked," the report said.

The company also reported $125 million in run-rate SG&A savings, including targeting marketing efficiencies, that could negatively impact its revenue, it added.

"We lower our estimates to be at low end of guidance this year & anticipate a prolonged turnaround," the note said.

The company took ownership of missteps, but trends have decelerated across cruise, the note said, adding that effectuating change is challenging amid elevated debt levels.

Morgan Stanley cut its price target to $20 from $23 while keeping its equal-weight rating.

Price: $17.25, Change: $+0.05, Percent Change: +0.26%

Related Articles

Wire

IAC Q1 Loss Narrows, Revenue Falls; Shares Drop After Hours

IAC (IAC) reported a Q1 loss late Monday of $0.94 per diluted share, narrowing from the loss of $2.64 a year earlier.Analysts polled by FactSet expected a loss of $0.37.Revenue in the three months ended March 31 fell to $422.9 million from $481.7 million a year earlier.Analysts surveyed by FactSet expected $520.3 million.IAC shares fell 8.6% in after-hours trading.

$IAC
Wire

Vornado Realty Trust Q1 Non-GAAP FFO, Revenue Fall; Shares Drop After Hours

Vornado Realty Trust (VNO) reported Q1 non-GAAP funds from operations late Monday of $0.52 per diluted share, down from $0.63 a year earlier.Analysts polled by FactSet expected $0.51.Revenue in the three months ended March 31 fell to $459.1 million from $461.6 million a year earlier.Analysts surveyed by FactSet expected $431.7 million.Vornado shares fell 3% in after-hours trading.

$VNO
Wire

GeneDx Q1 Swings to Adjusted Loss, Revenue Rises; 2026 Revenue Guidance Lowered; Shares Fall

GeneDx (WGS) reported Monday Q1 adjusted loss of $0.28 per diluted share, swinging from an adjusted earnings of $0.31 a year earlier.Analysts polled by FactSet expected loss of $0.02.Revenue for the quarter ended March 31 was $102.3 million, up from $87.1 million a year earlier.Analysts surveyed by FactSet expected $112.5 million.For Q2, the company expects revenue of $110 million to $112 million. Analysts expect $130.3 million.The company now expects 2026 revenue of $475 million to $490 million, down from $540 million to $555 million expected earlier. Analysts expect $550.0 million.Shares of the company were down over 45% during after-hours activity.

$WGS